Fig 1: Expression and visualization of fluorescent AVP and OT in neurohypophysis and in DRGs in transgenic rats. Confocal images showing AVP and OT fluorescence associated with neuronal cell bodies in freshly isolated neurohypophysis (NH), (a–c) and in DRG preparations (d–f) from transgenic AVP-eGFP (a,d), OT-mRFP (b,e) and AVP-eGFP/OT-mRFP transgenic homozygote male rats (c,f). Note clear separation of AVP and OT- fluorescent neurones in MH vs. co-localisation of both fluorescent signals in DRG neurones. Scale bars 50 µm.
Fig 2: OT and AVP are expressed in nociceptive DRG neurones. (a) Top panel: Confocal images DRG neurones cultured for 48 hours stained with antibodies against OT and TRPV1; the merged image shows co-localisation of both markers. Bottom panel: Confocal images of AVP-eGFP DRG neurones cultured for 48 hours and stained with TRPV1 antibody. The merged image shows co-localisation of both markers. Scale bars 50 µm. (b) AVP, OT and capsaicin-induced [Ca2+]i responses in cultured DRG neurones. Representative traces showing [Ca2+]i responses to AVP (100 nM), OT (100 nM), K+ (50 mM) and capsaicin (1 µM). (c) Pharmacology of AVP and OT-induced [Ca2+]i responses. Traces show AVP or OT-induced [Ca2+]i transients in control, in the presence of specific antagonist ([deamino-Pen1, O-Me-Tyr2, Arg8]-vasopressin or dOVT) and after washout. (d) Concentration dependence of AVP and OT-induced Ca2+ signals. The graph shows average peak amplitudes of [Ca2+]i transients at different concentrations of the agonist. (amplitudes are presented as mean ± SEM; experiments were performed on 6 AVP-eGFP neurones from 3 different cultures and 6 OT-mRFP neurones from 3 different cultures). (e) Average amplitudes (mean ± SEM), of [Ca2+]i transients triggered by AVP and OT in control conditions and in the presence of specific inhibitors of V1a receptors ([deamino-Pen1, O-Me-Tyr2, Arg8]-vasopressin; n = 6 AVP-eGFP neurones from 3 cultures; p = 0.0094, Friedman test) or OT receptors (dOVT; n = 5 OT-mRFP neurones from 3 cultures p = 0.0067, Friedman test).
Fig 3: Expression levels of P-LAP/IRAP and AVP in the (A) murine hippocampus and (B) pituitary gland. The expression level of P-LAP/IRAP was monitored by western blot analysis (top panel) and quantified by densitometric analysis (bottom panel). AVP levels (bottom panel) were monitored using a commercially available ELISA assay kit, as described in section “Materials and methods.” The LD cycle of the sacrificed animals is also shown in the figure.
Fig 4: Expression patterns of P-LAP/IRAP and AVP in several sub-regions of the murine brain. (A) Western blot analysis of P-LAP/IRAP distribution in several sub-regions of the murine brain. (B) Immunohistochemical localization of P-LAP/IRAP (green) and AVP (red) in several sub-regions of the murine brain. Higher-magnification views of the boxed areas in the merged images are shown at the bottom panel. CA2: cornu ammonis 2 area, CA3: cornu ammonis 3 area, 3V; 3rd ventricle, and opt; optic tract.
Fig 5: Effects of dehydration on AVP and OT expression in DRG Expression of endogenous fluorescence in DRG explants (lower panels) isolated from AVP-eGFP and OT-mRFP transgenic rats dehydrated for 3 (middle panels) and 5 days (right panels). The relative fluorescence expression in control preparations was taken as 100%. Dehydration affected fluorescence of neither AVP-eGFP nor OT-mRFP DRG explants, as quantified on bar graphs on the right. Scale bars 20 µm.
Supplier Page from Abcam for Arg8-Vasopressin ELISA Kit